Diaphorina citri psyllid: psy10212


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440----
YNVVNGELGFAKNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFENICFGVP
cccccccccccccCEEECcccccEEEEEEEEccccEEEEEEEEcccccEEEEEEEccccccccHHHHHHHHcccccEEEEEEEEcccccccccccccccccccccccccccccCEEEEccccccccccEEEEEEEcccccccccEEEEEEEEcccccEEEEEEccccccccccccccccccHHHccccccccEEEcHHHHcccccccccccccEEEEEEEccccccHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEccccccEEEECcccccccccccccCEEEECccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHHcccccccccccccccccccc
***VNGELGFAKNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY*PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFENI*****
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
YNVVNGELGFAKNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFENICFGVP

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Glycogen synthase kinase-3 beta Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity.confidentQ9WV60
Glycogen synthase kinase-3 Phosphorylates oma-1, a regulator of the oocyte-to-embryo transition, enabling its degradation. Phosphorylates skn-1, preventing it from accumulating in nuclei and thus inhibiting phase II gene expression in the oxidative stress defense. Involved in mesendoderm specification and mitotic spindle orientation in EMS blastomeres. Thought to be a branch point in these processes as proteins downstream are not required. Negatively regulates Wnt signaling in vulval precursor cells and acts as a Wnt-independent repressor of med-1 and med-2 in the C lineage inhibiting mesoderm development. Required for normal lifespan and LiCl-induced lifespan extension.confidentQ9U2Q9
Glycogen synthase kinase-3 beta Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity.confidentP18266

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0007165 [BP]signal transductionconfidentGO:0044700, GO:0051716, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0005829 [CC]cytosolconfidentGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0004672 [MF]protein kinase activityconfidentGO:0016773, GO:0016772, GO:0016301, GO:0003824, GO:0016740, GO:0003674
GO:0048523 [BP]negative regulation of cellular processconfidentGO:0008150, GO:0048519, GO:0065007, GO:0050789, GO:0050794
GO:0048522 [BP]positive regulation of cellular processconfidentGO:0048518, GO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0032880 [BP]regulation of protein localizationconfidentGO:0008150, GO:0032879, GO:0065007, GO:0050789
GO:0005886 [CC]plasma membraneconfidentGO:0005575, GO:0044464, GO:0016020, GO:0071944, GO:0005623
GO:0046777 [BP]protein autophosphorylationconfidentGO:0044267, GO:0006468, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0044237, GO:0008152, GO:0006793
GO:0005634 [CC]nucleusconfidentGO:0043231, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043227, GO:0043226
GO:0031323 [BP]regulation of cellular metabolic processconfidentGO:0008150, GO:0065007, GO:0050789, GO:0019222, GO:0050794
GO:0051246 [BP]regulation of protein metabolic processconfidentGO:0080090, GO:0019222, GO:0060255, GO:0008150, GO:0065007, GO:0050789
GO:0032991 [CC]macromolecular complexconfidentGO:0005575
GO:0018107 [BP]peptidyl-threonine phosphorylationprobableGO:0044267, GO:0006468, GO:0009987, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0018210, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0018193, GO:0008152, GO:0006793, GO:0044237
GO:0018105 [BP]peptidyl-serine phosphorylationprobableGO:0044267, GO:0006468, GO:0018209, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0018193, GO:0008152, GO:0006793, GO:0044237
GO:0045444 [BP]fat cell differentiationprobableGO:0032502, GO:0030154, GO:0048869, GO:0009987, GO:0044763, GO:0008150, GO:0044699
GO:0009742 [BP]brassinosteroid mediated signaling pathwayprobableGO:0070887, GO:0071383, GO:0023052, GO:0007165, GO:0043401, GO:0042221, GO:0050789, GO:0014070, GO:0009755, GO:0051716, GO:0033993, GO:0009719, GO:0071310, GO:0065007, GO:0044699, GO:0071495, GO:1901700, GO:0044700, GO:0009987, GO:0071396, GO:0050794, GO:0032870, GO:0044763, GO:0007154, GO:0010033, GO:0071367, GO:1901701, GO:0009741, GO:0071407, GO:0050896, GO:0009725, GO:0008150, GO:0097305, GO:0048545, GO:0097306
GO:0030010 [BP]establishment of cell polarityprobableGO:0008150, GO:0009987, GO:0007163, GO:0044763, GO:0044699
GO:0005730 [CC]nucleolusprobableGO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0002039 [MF]p53 bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0045121 [CC]membrane raftprobableGO:0005575, GO:0044425, GO:0016020
GO:0043198 [CC]dendritic shaftprobableGO:0044463, GO:0044464, GO:0030425, GO:0005575, GO:0097458, GO:0005623, GO:0043005, GO:0042995
GO:0008286 [BP]insulin receptor signaling pathwayprobableGO:0042221, GO:0007169, GO:0070887, GO:0023052, GO:0007165, GO:0007166, GO:0007167, GO:0032869, GO:0032868, GO:0050789, GO:0044699, GO:0009719, GO:0051716, GO:0071375, GO:1901698, GO:0071417, GO:0071310, GO:0065007, GO:0071495, GO:0044700, GO:0009987, GO:0050794, GO:0032870, GO:0044763, GO:0007154, GO:0043434, GO:0010033, GO:1901700, GO:1901701, GO:0009725, GO:0010243, GO:1901699, GO:1901652, GO:1901653, GO:0008150, GO:0050896
GO:0048471 [CC]perinuclear region of cytoplasmprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0032091 [BP]negative regulation of protein bindingprobableGO:0051098, GO:0051100, GO:0008150, GO:0065007, GO:0044092, GO:0043393, GO:0065009
GO:0032092 [BP]positive regulation of protein bindingprobableGO:0051099, GO:0051098, GO:0008150, GO:0065007, GO:0044093, GO:0043393, GO:0065009
GO:0046827 [BP]positive regulation of protein export from nucleusprobableGO:0033157, GO:0070201, GO:0032879, GO:0032388, GO:0060341, GO:0051050, GO:0051049, GO:0032386, GO:0090316, GO:0050794, GO:0008150, GO:0046824, GO:0046825, GO:0046822, GO:0048518, GO:0065007, GO:0051222, GO:0051223, GO:0050789, GO:0032880
GO:0033138 [BP]positive regulation of peptidyl-serine phosphorylationprobableGO:0019220, GO:0009893, GO:0019222, GO:0033135, GO:0031325, GO:0031323, GO:0050789, GO:0080090, GO:0010604, GO:0010562, GO:0051246, GO:0051247, GO:0032270, GO:0031399, GO:0048518, GO:0065007, GO:0045937, GO:0060255, GO:0050794, GO:0051174, GO:0008150, GO:0042325, GO:0042327, GO:0032268, GO:0031401, GO:0001932, GO:0001934, GO:0048522
GO:0034236 [MF]protein kinase A catalytic subunit bindingprobableGO:0051018, GO:0019899, GO:0019901, GO:0019900, GO:0003674, GO:0005488, GO:0005515
GO:0046627 [BP]negative regulation of insulin receptor signaling pathwayprobableGO:0009968, GO:0009966, GO:0048585, GO:0023051, GO:0048583, GO:0046626, GO:0050794, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:1900077, GO:1900076, GO:0048519, GO:0010646, GO:0050789, GO:0048523
GO:0043197 [CC]dendritic spineprobableGO:0044309, GO:0044463, GO:0044464, GO:0030425, GO:0005575, GO:0097458, GO:0005623, GO:0043005, GO:0042995
GO:0005524 [MF]ATP bindingprobableGO:0043168, GO:0003674, GO:0005488, GO:0030554, GO:0035639, GO:0097159, GO:1901363, GO:0043167, GO:0036094, GO:0032553, GO:0032559, GO:0001883, GO:0032549, GO:0032555, GO:0017076, GO:0000166, GO:0032550, GO:1901265, GO:0001882
GO:0030162 [BP]regulation of proteolysisprobableGO:0080090, GO:0019222, GO:0060255, GO:0051246, GO:0065007, GO:0008150, GO:0050789
GO:0045169 [CC]fusomeprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0005654 [CC]nucleoplasmprobableGO:0005575, GO:0043231, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422
GO:0043025 [CC]neuronal cell bodyprobableGO:0005575, GO:0097458, GO:0044297, GO:0005623, GO:0044464
GO:0046325 [BP]negative regulation of glucose importprobableGO:0051051, GO:0051049, GO:0008150, GO:0010827, GO:0065007, GO:0046324, GO:0048519, GO:0032879, GO:0010829, GO:0050789
GO:0010800 [BP]positive regulation of peptidyl-threonine phosphorylationprobableGO:0019220, GO:0080090, GO:0019222, GO:0031325, GO:0031323, GO:0050789, GO:0009893, GO:0010604, GO:0010562, GO:0051246, GO:0051247, GO:0032270, GO:0031399, GO:0048518, GO:0065007, GO:0045937, GO:0060255, GO:0050794, GO:0051174, GO:0008150, GO:0010799, GO:0042325, GO:0042327, GO:0032268, GO:0031401, GO:0001932, GO:0001934, GO:0048522
GO:0071285 [BP]cellular response to lithium ionprobableGO:0051716, GO:0071248, GO:0010038, GO:0050896, GO:0009987, GO:0071241, GO:0008150, GO:0044763, GO:0070887, GO:0042221, GO:0010226, GO:0010035, GO:0044699
GO:0000320 [BP]re-entry into mitotic cell cycleprobableGO:0022402, GO:0009987, GO:0008150, GO:0007049, GO:0044763, GO:0044699
GO:0031334 [BP]positive regulation of protein complex assemblyprobableGO:0051130, GO:0051128, GO:0044087, GO:0065007, GO:0048518, GO:0008150, GO:0043254, GO:0050794, GO:0050789, GO:0048522
GO:0035324 [CC]female germline ring canalprobableGO:0005575, GO:0005576, GO:0045171, GO:0044421, GO:0045172
GO:0006983 [BP]ER overload responseprobableGO:0006984, GO:0051716, GO:0009607, GO:0044700, GO:0050896, GO:0009987, GO:0008150, GO:0050794, GO:0023052, GO:0006950, GO:0065007, GO:0044763, GO:0007165, GO:0033554, GO:0007154, GO:0071216, GO:0050789, GO:0044699, GO:0034976
GO:0045892 [BP]negative regulation of transcription, DNA-dependentprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0008150, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0010558, GO:0048523
GO:0030529 [CC]ribonucleoprotein complexprobableGO:0032991, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044424
GO:0004712 [MF]protein serine/threonine/tyrosine kinase activityprobableGO:0016773, GO:0016772, GO:0016301, GO:0003824, GO:0016740, GO:0003674, GO:0004672
GO:0048156 [MF]tau protein bindingprobableGO:0003674, GO:0005488, GO:0005515, GO:0008092
GO:0043066 [BP]negative regulation of apoptotic processprobableGO:0043069, GO:0050794, GO:0008150, GO:0043067, GO:0065007, GO:0060548, GO:0048519, GO:0010941, GO:0042981, GO:0050789, GO:0048523
GO:0050321 [MF]tau-protein kinase activityprobableGO:0016773, GO:0016772, GO:0016301, GO:0003824, GO:0016740, GO:0003674, GO:0004672
GO:0005813 [CC]centrosomeprobableGO:0005856, GO:0005575, GO:0015630, GO:0043232, GO:0044464, GO:0005623, GO:0005815, GO:0044446, GO:0043229, GO:0043228, GO:0044430, GO:0044424, GO:0005622, GO:0043226, GO:0044422
GO:0005977 [BP]glycogen metabolic processprobableGO:0044042, GO:0044238, GO:0044264, GO:0044262, GO:0015980, GO:0044260, GO:0005976, GO:0009987, GO:0044710, GO:0044237, GO:0043170, GO:0008152, GO:0071704, GO:0006112, GO:0008150, GO:0006073, GO:0005975, GO:0006091, GO:0055114
GO:0072686 [CC]mitotic spindleprobableGO:0043234, GO:0005856, GO:0015630, GO:0032991, GO:0005575, GO:0043232, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0043229, GO:0005819, GO:0044430, GO:0044424, GO:0043228, GO:0043226, GO:0044422
GO:0030426 [CC]growth coneprobableGO:0030427, GO:0044463, GO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0006611 [BP]protein export from nucleusprobableGO:0051169, GO:0051168, GO:0016482, GO:0008104, GO:0044699, GO:0070727, GO:0006886, GO:0071702, GO:0033036, GO:0034613, GO:0006810, GO:0006913, GO:0045184, GO:0044765, GO:0044763, GO:0051649, GO:0051234, GO:0051179, GO:0051641, GO:0046907, GO:0015031, GO:0008150, GO:0009987
GO:0060069 [BP]Wnt receptor signaling pathway, regulating spindle positioningprobableGO:0044700, GO:0051716, GO:0009987, GO:0008150, GO:0044699, GO:0050896, GO:0016055, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0050789, GO:0035567
GO:0051124 [BP]synaptic growth at neuromuscular junctionprobableGO:0050808, GO:0048589, GO:0030154, GO:0048468, GO:0014706, GO:0022607, GO:0051146, GO:0061061, GO:0007275, GO:0044699, GO:0007517, GO:0040007, GO:0048869, GO:0071840, GO:0007519, GO:0016043, GO:0048513, GO:0007416, GO:0032502, GO:0055001, GO:0055002, GO:0032501, GO:0048741, GO:0009987, GO:0009888, GO:0048747, GO:0044767, GO:0044763, GO:0048731, GO:0007528, GO:0044707, GO:0007399, GO:0048856, GO:0044085, GO:0060537, GO:0060538, GO:0008150, GO:0042692
GO:0030707 [BP]ovarian follicle cell developmentprobableGO:0048610, GO:0030154, GO:0048468, GO:0019953, GO:0007292, GO:0007276, GO:0000003, GO:0048869, GO:0044699, GO:0048477, GO:0032502, GO:0032501, GO:0048609, GO:0032504, GO:0009987, GO:0044767, GO:0022414, GO:0044763, GO:0022412, GO:0044702, GO:0003006, GO:0048856, GO:0008150
GO:0008283 [BP]cell proliferationprobableGO:0008150, GO:0044699
GO:0008355 [BP]olfactory learningprobableGO:0032501, GO:0007635, GO:0044707, GO:0042048, GO:0044708, GO:0050896, GO:0007612, GO:0007610, GO:0007611, GO:0008306, GO:0008150, GO:0050890, GO:0050877, GO:0042221, GO:0044699, GO:0003008
GO:0009733 [BP]response to auxin stimulusprobableGO:0009719, GO:0009725, GO:0050896, GO:0008150, GO:0042221, GO:0010033
GO:0040010 [BP]positive regulation of growth rateprobableGO:0045927, GO:0040008, GO:0040009, GO:0065007, GO:0048518, GO:0008150, GO:0050789
GO:0001837 [BP]epithelial to mesenchymal transitionprobableGO:0030154, GO:0048468, GO:0009653, GO:0007275, GO:0044699, GO:0014031, GO:0048864, GO:0000902, GO:0048869, GO:0016043, GO:0032989, GO:0008150, GO:0048513, GO:0071840, GO:0032502, GO:0048762, GO:0032501, GO:0009987, GO:0009888, GO:0044767, GO:0048863, GO:0044763, GO:0060485, GO:0000904, GO:0044707, GO:0048856, GO:0048731
GO:0007367 [BP]segment polarity determinationprobableGO:0032502, GO:0007389, GO:0032501, GO:0009880, GO:0044707, GO:0007365, GO:0048856, GO:0044767, GO:0009790, GO:0008150, GO:0003002, GO:0035282, GO:0007350, GO:0007275, GO:0044699
GO:0045719 [BP]negative regulation of glycogen biosynthetic processprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010906, GO:0048519, GO:0032885, GO:0050789, GO:0032881, GO:0043255, GO:0010605, GO:0019222, GO:0043467, GO:2000112, GO:2000113, GO:0065007, GO:0010962, GO:0045912, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0010675, GO:0010677, GO:0070873, GO:0070874, GO:0005979, GO:0010556, GO:0006109, GO:0010558, GO:0048523
GO:0045842 [BP]positive regulation of mitotic metaphase/anaphase transitionprobableGO:0045840, GO:0033043, GO:0051128, GO:1901990, GO:1901992, GO:0030071, GO:0090068, GO:0007346, GO:0045787, GO:0010564, GO:0050789, GO:0065007, GO:0048518, GO:0007088, GO:0051130, GO:0051785, GO:0050794, GO:1901987, GO:0008150, GO:1902099, GO:1901989, GO:0051726, GO:0010638, GO:0051783, GO:1902101, GO:0048522
GO:0002119 [BP]nematode larval developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0009791, GO:0002164, GO:0008150, GO:0007275, GO:0044699
GO:0031625 [MF]ubiquitin protein ligase bindingprobableGO:0003674, GO:0044389, GO:0005515, GO:0019899, GO:0005488
GO:0055013 [BP]cardiac muscle cell developmentprobableGO:0030154, GO:0048468, GO:0014706, GO:0072358, GO:0051146, GO:0061061, GO:0007275, GO:0044699, GO:0048869, GO:0008150, GO:0048513, GO:0032502, GO:0055001, GO:0055002, GO:0032501, GO:0055006, GO:0055007, GO:0009987, GO:0035051, GO:0009888, GO:0044767, GO:0044763, GO:0007507, GO:0044707, GO:0048856, GO:0072359, GO:0048738, GO:0060537, GO:0048731, GO:0042692
GO:0007219 [BP]Notch signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0050789, GO:0044699
GO:0007173 [BP]epidermal growth factor receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0007154, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007167, GO:0007169, GO:0050789, GO:0044699, GO:0038127
GO:0051519 [BP]activation of bipolar cell growthprobableGO:0048639, GO:0048638, GO:0045927, GO:0022603, GO:0030307, GO:0051128, GO:0022604, GO:0050789, GO:0040008, GO:0065007, GO:0048518, GO:0051130, GO:0050793, GO:0050794, GO:0001558, GO:0008150, GO:0051518, GO:0051094, GO:0051512, GO:0051510, GO:0051516, GO:0048522
GO:0071109 [BP]superior temporal gyrus developmentprobableGO:0032502, GO:0021537, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0007275, GO:0044767, GO:0021543, GO:0048513, GO:0008150, GO:0048731, GO:0030900, GO:0021987, GO:0044699, GO:0007417
GO:0007622 [BP]rhythmic behaviorprobableGO:0044708, GO:0050896, GO:0008150, GO:0007610, GO:0048511
GO:0003073 [BP]regulation of systemic arterial blood pressureprobableGO:0032501, GO:0044707, GO:0008015, GO:0008150, GO:0003013, GO:0065007, GO:0008217, GO:0065008, GO:0044699, GO:0003008
GO:0030877 [CC]beta-catenin destruction complexprobableGO:0043234, GO:0005737, GO:0032991, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0030496 [CC]midbodyprobableGO:0005575, GO:0044464, GO:0005623
GO:0009933 [BP]meristem structural organizationprobableGO:0032502, GO:0044767, GO:0032501, GO:0044707, GO:0048856, GO:0009888, GO:0048507, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0048532, GO:0007275, GO:0044699
GO:0006917 [BP]induction of apoptosisprobableGO:0050789, GO:0043067, GO:0050794, GO:0043065, GO:0048518, GO:0012502, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0044027 [BP]hypermethylation of CpG islandprobableGO:0080090, GO:0019222, GO:0060255, GO:0031323, GO:0050794, GO:0019219, GO:0065007, GO:0051171, GO:0044026, GO:0044030, GO:0008150, GO:0050789, GO:0051052
GO:0003214 [BP]cardiac left ventricle morphogenesisprobableGO:0003205, GO:0044767, GO:0009887, GO:0003206, GO:0044707, GO:0007507, GO:0048513, GO:0032501, GO:0048856, GO:0003208, GO:0003007, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0003231, GO:0009653, GO:0032502, GO:0007275, GO:0044699
GO:0071775 []regulation of cell cycle cytokinesisprobable
GO:0006349 [BP]regulation of gene expression by genetic imprintingprobableGO:0006139, GO:0071514, GO:0019222, GO:0044238, GO:0060255, GO:0009987, GO:0006725, GO:0040029, GO:0044237, GO:0050789, GO:0071704, GO:0034641, GO:0006807, GO:0008150, GO:0008152, GO:0065007, GO:0010468, GO:1901360, GO:0046483
GO:0061052 [BP]negative regulation of cell growth involved in cardiac muscle cell developmentprobableGO:0014741, GO:0045843, GO:0014743, GO:0045926, GO:0051239, GO:0030308, GO:0048638, GO:0048635, GO:0048634, GO:0051128, GO:0051147, GO:0051148, GO:0043502, GO:0050789, GO:0044057, GO:0040008, GO:0051241, GO:0060284, GO:0046620, GO:0065007, GO:0048640, GO:0048519, GO:1901861, GO:0016202, GO:0060420, GO:1901862, GO:2000725, GO:0055026, GO:0046621, GO:0055024, GO:0055022, GO:0055021, GO:0051153, GO:0061117, GO:0001558, GO:0008150, GO:0090257, GO:0051154, GO:0050794, GO:0061050, GO:0051093, GO:0010611, GO:0010614, GO:0045596, GO:0045595, GO:0050793, GO:2000026, GO:0048523
GO:0031288 [BP]sorocarp morphogenesisprobableGO:0030582, GO:0030587, GO:0061458, GO:0019954, GO:0009991, GO:0075259, GO:0042594, GO:0009653, GO:0007275, GO:0044699, GO:0000003, GO:0048513, GO:0032502, GO:0032501, GO:0048608, GO:0044767, GO:0022414, GO:0006950, GO:0008150, GO:0055084, GO:0044707, GO:0009605, GO:0003006, GO:0050896, GO:0048856, GO:0031667, GO:0048731
GO:0009649 [BP]entrainment of circadian clockprobableGO:0009605, GO:0050896, GO:0042752, GO:0065007, GO:0008150, GO:0050789
GO:0000165 [BP]MAPK cascadeprobableGO:0044700, GO:0051716, GO:0007243, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0035556, GO:0050789, GO:0044699
GO:0035372 [BP]protein localization to microtubuleprobableGO:0008104, GO:0070727, GO:0034613, GO:0044380, GO:0072698, GO:0044763, GO:0033365, GO:0008150, GO:0009987, GO:0033036, GO:0051179, GO:0044699, GO:0051641
GO:0007520 [BP]myoblast fusionprobableGO:0030154, GO:0061061, GO:0014706, GO:0000768, GO:0006949, GO:0009653, GO:0007275, GO:0044699, GO:0007517, GO:0051146, GO:0007519, GO:0048513, GO:0048869, GO:0035914, GO:0048646, GO:0032502, GO:0032501, GO:0014902, GO:0009987, GO:0009888, GO:0044767, GO:0044763, GO:0048731, GO:0044707, GO:0048856, GO:0060537, GO:0060538, GO:0008150, GO:0042692
GO:0035188 [BP]hatchingprobableGO:0071684, GO:0032502, GO:0032501, GO:0044707, GO:0008150, GO:0007275, GO:0044699
GO:0042176 [BP]regulation of protein catabolic processprobableGO:0009894, GO:0080090, GO:0019222, GO:0060255, GO:0051246, GO:0065007, GO:0008150, GO:0050789
GO:0030819 [BP]positive regulation of cAMP biosynthetic processprobableGO:0019220, GO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:0031323, GO:1900371, GO:0045981, GO:0080090, GO:0030816, GO:0030817, GO:0030814, GO:0009891, GO:0030810, GO:0050789, GO:0065007, GO:0048518, GO:0045935, GO:0045937, GO:0019219, GO:0009889, GO:0050794, GO:0051174, GO:0008150, GO:0051171, GO:0051173, GO:0030799, GO:0030808, GO:1900542, GO:1900544, GO:0030804, GO:0030801, GO:1900373, GO:0030802, GO:0006140, GO:0010562, GO:0048522
GO:0051984 [BP]positive regulation of chromosome segregationprobableGO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0051983, GO:0048522
GO:0008353 [MF]RNA polymerase II carboxy-terminal domain kinase activityprobableGO:0003824, GO:0016773, GO:0016772, GO:0016301, GO:0004674, GO:0016740, GO:0003674, GO:0004672
GO:0009825 [BP]multidimensional cell growthprobableGO:0016049, GO:0040007, GO:0009987, GO:0008150, GO:0044763, GO:0044699
GO:0090090 [BP]negative regulation of canonical Wnt receptor signaling pathwayprobableGO:0009968, GO:0008150, GO:0009966, GO:0048585, GO:0048583, GO:0048519, GO:0050794, GO:0050789, GO:0023057, GO:0030111, GO:0065007, GO:0010648, GO:0023051, GO:0048523, GO:0010646, GO:0030178, GO:0060828
GO:0051059 [MF]NF-kappaB bindingprobableGO:0008134, GO:0003674, GO:0005488, GO:0005515
GO:2000466 [BP]negative regulation of glycogen (starch) synthase activityprobableGO:0051348, GO:0019222, GO:2000465, GO:0050790, GO:0051338, GO:0050789, GO:0065007, GO:0044092, GO:0008150, GO:0065009, GO:0043086
GO:2000467 [BP]positive regulation of glycogen (starch) synthase activityprobableGO:0051347, GO:0019222, GO:2000465, GO:0050790, GO:0051338, GO:0065007, GO:0044093, GO:0008150, GO:0065009, GO:0050789, GO:0043085
GO:0033047 [BP]regulation of mitotic sister chromatid segregationprobableGO:0033044, GO:0033045, GO:0007346, GO:0033043, GO:0051726, GO:0010564, GO:0050794, GO:0051783, GO:0065007, GO:0008150, GO:0051128, GO:0007088, GO:0050789, GO:0051983
GO:0032886 [BP]regulation of microtubule-based processprobableGO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0001947 [BP]heart loopingprobableGO:0032502, GO:0009790, GO:0072359, GO:0072358, GO:0009799, GO:0009653, GO:0007275, GO:0044699, GO:0002009, GO:0007368, GO:0048513, GO:0048729, GO:0060562, GO:0061371, GO:0048598, GO:0009887, GO:0032501, GO:0035239, GO:0007507, GO:0060429, GO:0035050, GO:0009888, GO:0003007, GO:0007389, GO:0008150, GO:0035295, GO:0003143, GO:0044707, GO:0048856, GO:0044767, GO:0009855, GO:0048731
GO:0035293 [BP]chitin-based larval cuticle pattern formationprobableGO:0032502, GO:0042337, GO:0042335, GO:0044707, GO:0007389, GO:0032501, GO:0048856, GO:0007591, GO:0007275, GO:0008363, GO:0002165, GO:0002164, GO:0044767, GO:0003002, GO:0035017, GO:0008150, GO:0009791, GO:0042303, GO:0040003, GO:0044699, GO:0002168
GO:0046959 [BP]habituationprobableGO:0032501, GO:0044707, GO:0007612, GO:0050896, GO:0050890, GO:0007610, GO:0007611, GO:0008150, GO:0044699, GO:0046958, GO:0044708, GO:0050877, GO:0003008
GO:0009965 [BP]leaf morphogenesisprobableGO:0032502, GO:0048513, GO:0009887, GO:0032501, GO:0044707, GO:0048856, GO:0048367, GO:0044767, GO:0048366, GO:0048827, GO:0008150, GO:0010016, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0048011 [BP]neurotrophin TRK receptor signaling pathwayprobableGO:0007166, GO:0007167, GO:0023052, GO:0007165, GO:0070887, GO:0007154, GO:0007169, GO:0050789, GO:0044699, GO:0051716, GO:0070848, GO:0071310, GO:0065007, GO:0038179, GO:0009987, GO:0050794, GO:0008150, GO:0042221, GO:0010033, GO:0044700, GO:0071363, GO:0050896, GO:0044763
GO:0008543 [BP]fibroblast growth factor receptor signaling pathwayprobableGO:0007166, GO:0007167, GO:0070848, GO:0023052, GO:0007165, GO:0070887, GO:0042221, GO:0007169, GO:0050789, GO:0044699, GO:0009719, GO:0051716, GO:0044344, GO:0071310, GO:0065007, GO:0071495, GO:0009987, GO:0050794, GO:0044763, GO:0007154, GO:0010033, GO:0044700, GO:0071363, GO:0050896, GO:0071774, GO:0008150
GO:2000077 [BP]negative regulation of type B pancreatic cell developmentprobableGO:0051093, GO:0050793, GO:2000074, GO:0060284, GO:0050794, GO:0008150, GO:0045596, GO:0045595, GO:0065007, GO:0030856, GO:0048519, GO:0051239, GO:0010721, GO:2000026, GO:0050789, GO:0048523
GO:0001954 [BP]positive regulation of cell-matrix adhesionprobableGO:0045785, GO:0010810, GO:0010811, GO:0030155, GO:0001952, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0043508 [BP]negative regulation of JUN kinase activityprobableGO:0033673, GO:0009892, GO:0043549, GO:0019220, GO:0080090, GO:0019222, GO:0044092, GO:0048585, GO:0031324, GO:0048583, GO:0043407, GO:0023057, GO:0043405, GO:0010648, GO:0023051, GO:0043506, GO:0046328, GO:0071901, GO:0071900, GO:0010627, GO:0043086, GO:0043409, GO:0043408, GO:0051248, GO:0010646, GO:0010605, GO:0009968, GO:0009966, GO:0051348, GO:0051246, GO:0050789, GO:0060255, GO:0065007, GO:0031399, GO:0048519, GO:0065009, GO:0010741, GO:0006469, GO:0045936, GO:0070302, GO:0031323, GO:0045859, GO:0050794, GO:0032872, GO:0032268, GO:0008150, GO:0042325, GO:0051174, GO:0032269, GO:0042326, GO:0050790, GO:0010563, GO:0031400, GO:0080135, GO:0051338, GO:0001933, GO:0001932, GO:0080134, GO:0048523
GO:0003146 [BP]heart joggingprobableGO:0032502, GO:0009790, GO:0072359, GO:0072358, GO:0009799, GO:0009653, GO:0007275, GO:0044699, GO:0002009, GO:0007368, GO:0048513, GO:0048729, GO:0060562, GO:0061371, GO:0048598, GO:0009887, GO:0032501, GO:0035239, GO:0007507, GO:0060429, GO:0035050, GO:0009888, GO:0003007, GO:0007389, GO:0008150, GO:0035295, GO:0003143, GO:0044707, GO:0048856, GO:0044767, GO:0009855, GO:0048731
GO:0060176 [BP]regulation of aggregation involved in sorocarp developmentprobableGO:0032107, GO:0032104, GO:0032101, GO:0050793, GO:0080134, GO:2000241, GO:0048583, GO:0075260, GO:0008150, GO:0031155, GO:0031156, GO:2000026, GO:0051239, GO:0065007, GO:0050789
GO:0009792 [BP]embryo development ending in birth or egg hatchingprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0008150, GO:0007275, GO:0044699
GO:0010467 [BP]gene expressionprobableGO:0071704, GO:0008150, GO:0008152, GO:0043170
GO:0000302 [BP]response to reactive oxygen speciesprobableGO:1901700, GO:0050896, GO:0006950, GO:0008150, GO:0042221, GO:0006979
GO:0035309 [BP]wing and notum subfield formationprobableGO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0007444, GO:0048856, GO:0035220, GO:0044767, GO:0048513, GO:0008150, GO:0003002, GO:0048731, GO:0007275, GO:0044699
GO:0035019 [BP]somatic stem cell maintenanceprobableGO:0030154, GO:0048468, GO:0050789, GO:0044699, GO:0048863, GO:0048864, GO:0048869, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0044767, GO:0045596, GO:0045595, GO:0008150, GO:0051093, GO:0019827, GO:0044707, GO:0048856, GO:0044763, GO:0048523
GO:0007476 [BP]imaginal disc-derived wing morphogenesisprobableGO:0048563, GO:0048569, GO:0035107, GO:0009887, GO:0035220, GO:0009791, GO:0035120, GO:0002165, GO:0032501, GO:0009653, GO:0007275, GO:0044699, GO:0007472, GO:0007552, GO:0048513, GO:0032502, GO:0048707, GO:0009886, GO:0035114, GO:0008150, GO:0044767, GO:0044707, GO:0007444, GO:0048856, GO:0007560, GO:0048731, GO:0048736, GO:0048737
GO:0007143 [BP]female meiosisprobableGO:0007126, GO:0048610, GO:0051321, GO:0000003, GO:0009987, GO:0008150, GO:0044763, GO:0044699, GO:0022402, GO:0007049
GO:0032855 [BP]positive regulation of Rac GTPase activityprobableGO:0009894, GO:0019220, GO:0080090, GO:0019222, GO:0035023, GO:0046578, GO:0023051, GO:0010646, GO:0043087, GO:0050789, GO:0043085, GO:0032319, GO:0032318, GO:0043547, GO:0051345, GO:0009966, GO:0031323, GO:0030811, GO:0065007, GO:0044093, GO:0065009, GO:0051056, GO:0033121, GO:0033124, GO:0019219, GO:0048583, GO:0050790, GO:0050794, GO:0051174, GO:0008150, GO:0051171, GO:0009118, GO:0051336, GO:1900542, GO:0032320, GO:0032321, GO:0031329, GO:0006140
GO:0001085 [MF]RNA polymerase II transcription factor bindingprobableGO:0008134, GO:0003674, GO:0005488, GO:0005515
GO:0009953 [BP]dorsal/ventral pattern formationprobableGO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0008150, GO:0003002, GO:0007275, GO:0044699
GO:0048232 [BP]male gamete generationprobableGO:0044702, GO:0000003, GO:0032504, GO:0019953, GO:0022414, GO:0032501, GO:0008150, GO:0044699, GO:0007276, GO:0048609
GO:2000738 [BP]positive regulation of stem cell differentiationprobableGO:2000736, GO:0051094, GO:0050793, GO:0050794, GO:0045597, GO:0045595, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0043652 [BP]engulfment of apoptotic cellprobableGO:0009987, GO:0006909, GO:0016192, GO:0016044, GO:0071840, GO:0006810, GO:0010324, GO:0006911, GO:0008150, GO:0061024, GO:0044765, GO:0044763, GO:0016043, GO:0043277, GO:0006897, GO:0051234, GO:0051179, GO:0044699
GO:0016477 [BP]cell migrationprobableGO:0040011, GO:0048870, GO:0009987, GO:0006928, GO:0051674, GO:0044763, GO:0008150, GO:0051179, GO:0044699
GO:0035255 [MF]ionotropic glutamate receptor bindingprobableGO:0005102, GO:0003674, GO:0005488, GO:0005515, GO:0035254
GO:0031154 [BP]culmination involved in sorocarp developmentprobableGO:0030582, GO:0030587, GO:0061458, GO:0019954, GO:0009991, GO:0075259, GO:0042594, GO:0007275, GO:0044699, GO:0000003, GO:0048513, GO:0032502, GO:0032501, GO:0048608, GO:0044767, GO:0022414, GO:0006950, GO:0008150, GO:0055084, GO:0044707, GO:0009605, GO:0003006, GO:0050896, GO:0048856, GO:0031667, GO:0048731
GO:0050774 [BP]negative regulation of dendrite morphogenesisprobableGO:0022604, GO:0044707, GO:0051239, GO:0022603, GO:0030154, GO:0051129, GO:0051128, GO:0060284, GO:0031345, GO:0031344, GO:0044699, GO:0050767, GO:0048869, GO:0050768, GO:0050789, GO:0045664, GO:0010769, GO:0065007, GO:0010721, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045596, GO:0045595, GO:0044763, GO:0010975, GO:0048731, GO:0022008, GO:0051093, GO:0048699, GO:0007399, GO:0050773, GO:0048856, GO:0051960, GO:2000026, GO:0048814, GO:0007275, GO:0008150, GO:0048523
GO:0051534 [BP]negative regulation of NFAT protein import into nucleusprobableGO:0033157, GO:0060341, GO:0051049, GO:0032386, GO:0032387, GO:0051223, GO:0051224, GO:0050789, GO:0032880, GO:0065007, GO:0048519, GO:0070201, GO:0051051, GO:0090317, GO:0050794, GO:0008150, GO:0042308, GO:0042306, GO:0032879, GO:0042992, GO:0042990, GO:1900180, GO:0051532, GO:0046822, GO:0046823
GO:0044337 [BP]canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic processprobableGO:0023052, GO:0007165, GO:0007166, GO:0010942, GO:0010941, GO:0042981, GO:0050789, GO:0044699, GO:0051716, GO:0043065, GO:0043067, GO:0065007, GO:0048518, GO:0043068, GO:0009987, GO:0050794, GO:0060070, GO:0044763, GO:0007154, GO:0044700, GO:0050896, GO:0016055, GO:0008150, GO:0048522
GO:0008584 [BP]male gonad developmentprobableGO:0032502, GO:0022414, GO:0007548, GO:0032501, GO:0048608, GO:0000003, GO:0044707, GO:0046546, GO:0061458, GO:0048856, GO:0008406, GO:0045137, GO:0007275, GO:0044767, GO:0003006, GO:0048513, GO:0008150, GO:0048731, GO:0046661, GO:0044699
GO:0006987 [BP]activation of signaling protein activity involved in unfolded protein responseprobableGO:0032069, GO:0048522, GO:0019220, GO:0080090, GO:0019222, GO:0033674, GO:0051246, GO:0031325, GO:0031323, GO:0023052, GO:0007165, GO:0070887, GO:0042221, GO:0050789, GO:0043085, GO:0009893, GO:0006984, GO:0051716, GO:0006986, GO:0051347, GO:0010604, GO:0051345, GO:0010562, GO:0043549, GO:0034976, GO:0051247, GO:0019219, GO:0071310, GO:0032270, GO:0044699, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0065009, GO:0042325, GO:0050790, GO:0045937, GO:0060255, GO:0045859, GO:0032075, GO:0051174, GO:0006950, GO:0032268, GO:0044763, GO:0051171, GO:0007154, GO:0050794, GO:0010033, GO:0051336, GO:0044700, GO:0042327, GO:0045860, GO:0030968, GO:0050896, GO:0031401, GO:0051338, GO:0035967, GO:0035966, GO:0033554, GO:0008150, GO:0009987, GO:0001932, GO:0001934, GO:0034620
GO:0061118 [BP]regulation of positive chemotaxis to cAMPprobableGO:0040012, GO:0032101, GO:0048583, GO:0050795, GO:0008150, GO:0050926, GO:0050920, GO:0065007, GO:0050789
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0005178 [MF]integrin bindingprobableGO:0032403, GO:0005102, GO:0003674, GO:0005488, GO:0005515
GO:0004713 [MF]protein tyrosine kinase activityprobableGO:0016773, GO:0016772, GO:0016301, GO:0003824, GO:0016740, GO:0003674, GO:0004672
GO:0007281 [BP]germ cell developmentprobableGO:0032502, GO:0044702, GO:0048609, GO:0032504, GO:0022414, GO:0048869, GO:0032501, GO:0030154, GO:0048468, GO:0019953, GO:0044767, GO:0003006, GO:0048610, GO:0044763, GO:0044699, GO:0022412, GO:0008150, GO:0009987, GO:0000003, GO:0007276, GO:0048856
GO:0007052 [BP]mitotic spindle organizationprobableGO:0006996, GO:0007017, GO:0007010, GO:0000278, GO:0071822, GO:0043933, GO:0071840, GO:0009987, GO:0044763, GO:0016043, GO:0008150, GO:0007051, GO:0022402, GO:0044699, GO:0000226, GO:0007049
GO:0032007 [BP]negative regulation of TOR signaling cascadeprobableGO:0009968, GO:0009966, GO:0048585, GO:0048583, GO:0048519, GO:0050794, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0032006, GO:0010646, GO:0050789, GO:0048523
GO:0021766 [BP]hippocampus developmentprobableGO:0032502, GO:0021537, GO:0032501, GO:0007420, GO:0044707, GO:0048856, GO:0007399, GO:0044767, GO:0021543, GO:0048513, GO:0030900, GO:0008150, GO:0021761, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0045886 [BP]negative regulation of synaptic growth at neuromuscular junctionprobableGO:0048638, GO:0019226, GO:0045926, GO:0035637, GO:0050803, GO:0008582, GO:0007268, GO:0050807, GO:0048634, GO:0051129, GO:0051128, GO:0032501, GO:0023052, GO:0051147, GO:0050789, GO:0044699, GO:0040008, GO:0060284, GO:0065007, GO:0048640, GO:0048519, GO:0065008, GO:1901861, GO:0016202, GO:0009987, GO:0050793, GO:0050877, GO:0048742, GO:0050794, GO:0051153, GO:0045595, GO:0044763, GO:0051239, GO:0048641, GO:0007267, GO:0007154, GO:0003008, GO:0051093, GO:0044700, GO:0044707, GO:0051963, GO:0044087, GO:0051961, GO:0051960, GO:2000026, GO:0051964, GO:0008150, GO:0048523
GO:0072347 [BP]response to anestheticprobableGO:0008150, GO:0042221, GO:0050896, GO:0042493
GO:0004707 [MF]MAP kinase activityprobableGO:0016301, GO:0004674, GO:0016773, GO:0005057, GO:0003824, GO:0004702, GO:0060089, GO:0016740, GO:0003674, GO:0004871, GO:0004672, GO:0016772
GO:0071879 [BP]positive regulation of adrenergic receptor signaling pathwayprobableGO:0023056, GO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0050794, GO:0071877, GO:0008277, GO:0045745, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0050789, GO:0048522
GO:0006898 [BP]receptor-mediated endocytosisprobableGO:0006897, GO:0016192, GO:0006810, GO:0008150, GO:0051234, GO:0051179
GO:0045610 [BP]regulation of hemocyte differentiationprobableGO:0050793, GO:0050794, GO:0008150, GO:0045595, GO:0002682, GO:0051239, GO:0065007, GO:0050789
GO:0030435 [BP]sporulation resulting in formation of a cellular sporeprobableGO:0032502, GO:0048856, GO:0048869, GO:0030154, GO:0043934, GO:0044767, GO:0044763, GO:0044699, GO:0008150, GO:0009987, GO:0009653, GO:0048646
GO:0042538 [BP]hyperosmotic salinity responseprobableGO:0009628, GO:0050896, GO:0008150, GO:0006950, GO:0006970, GO:0006972, GO:0009651
GO:0009729 [BP]detection of brassinosteroid stimulusprobableGO:1901700, GO:0009719, GO:0050896, GO:0009593, GO:0051606, GO:0009741, GO:0033993, GO:0009726, GO:0009720, GO:0008150, GO:0009725, GO:0042221, GO:0097305, GO:0010033, GO:0014070
GO:0048168 [BP]regulation of neuronal synaptic plasticityprobableGO:0065008, GO:0044057, GO:0031644, GO:0050804, GO:0048167, GO:0065007, GO:0051239, GO:0023051, GO:0008150, GO:0051969, GO:0010646, GO:0050789, GO:0050794
GO:0048015 [BP]phosphatidylinositol-mediated signalingprobableGO:0044700, GO:0051716, GO:0044699, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0035556, GO:0050789, GO:0048017
GO:0007423 [BP]sensory organ developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0045823 [BP]positive regulation of heart contractionprobableGO:0044057, GO:0051240, GO:0008016, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0050789
GO:0008013 [MF]beta-catenin bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0007411 [BP]axon guidanceprobableGO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0031175, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0042330, GO:0048869, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0006935, GO:0030182, GO:0009987, GO:0044767, GO:0008150, GO:0007409, GO:0048731, GO:0042221, GO:0022008, GO:0048858, GO:0040011, GO:0048699, GO:0032990, GO:0009605, GO:0050896, GO:0048856, GO:0007399, GO:0048812, GO:0044763
GO:0007569 [BP]cell agingprobableGO:0032502, GO:0007568, GO:0009987, GO:0044767, GO:0044763, GO:0008150, GO:0044699
GO:0031333 [BP]negative regulation of protein complex assemblyprobableGO:0009987, GO:0051129, GO:0051128, GO:0008150, GO:0044087, GO:0065007, GO:0044763, GO:0044699, GO:0048519, GO:0043254, GO:0050794, GO:0050789, GO:0048523

Prediction of Enzyme Commission Number ?

EC Number ?Description ?Confidence Level ?
2.-.-.-Transferases.probable
2.7.-.-Transferring phosphorous-containing groups.probable
2.7.11.-Protein-serine/threonine kinases.probable

Spatial Structural Prediction

Structural Models Based on Templates

Template: 4E7W, chain A
Confidence level:very confident
Coverage over the Query: 20-92,213-436
View the alignment between query and template
View the model in PyMOL
Template: 3EB0, chain A
Confidence level:very confident
Coverage over the Query: 21-87,213-435
View the alignment between query and template
View the model in PyMOL
Template: 3QD2, chain B
Confidence level:very confident
Coverage over the Query: 18-89,166-168,206-369,395-432
View the alignment between query and template
View the model in PyMOL
Template: 4DIT, chain A
Confidence level:very confident
Coverage over the Query: 112-372,389-433
View the alignment between query and template
View the model in PyMOL